Graphite Bio is harnessing the unprecedented power of targeted DNA integration to cure serious diseases

Co-founded by academic pioneers in the fields of gene editing and gene therapy, Graphite Bio is a next-generation gene editing company focused on the development of best-in-disease therapies for patients suffering from serious genetic disorders and beyond. The company’s gene editing platform harnesses the power of CRISPR and natural DNA repair processes to achieve highly efficient targeted DNA integration to precisely repair genetic defects at their source.